Skip to main content
FinSpry Logo
FinSpry
EVMN logo
EVMN
(NYSE)
Evommune, Inc.
$23.72-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Evommune (EVMN) Stock Price & Financial Analysis

Evommune Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$22.08 - $23.89
52-Week High$33.20
52-Week Low$13.89
Open$22.08
Volume380.59K
Average Volume (3M)380.59K
Market Cap747.75M
Shares Outstanding31.52M
Price to Sales (P/S)54.37
Price to Book (P/B)3.44
EV/EBITDA-9.53
Revenue (TTM)13.00M
Net Income (TTM)-68.87M
Free Cash Flow (TTM)-76.68M
EPS (TTM)$-2.18
Profit Margin-529.77%
Operating Margin-623.62%
Return on Equity (ROE)-33.50%
Debt to Equity0.01
50-Day MA$23.60
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Evommune

What is the current stock price for EVMN?

As of the latest trading session, EVMN stock trades at $23.72. The 52-week range is $13.89–$33.20, with a day range of $22.08–$23.89.

What is the P/E ratio for EVMN?

The P/E ratio (Price-to-Earnings) for EVMN is shown in the Key Statistics section. This valuation metric helps compare Evommune, Inc. to industry peers.

Does EVMN pay dividends?

Evommune does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for EVMN?

Based on 7 analysts, the consensus for EVMN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of EVMN?

Evommune's market capitalization is $747.8M, classifying it as a small-cap company. Evommune operates in the Healthcare sector within the Biotechnology industry.